Exelixis (EXEL) Total Current Liabilities (2010 - 2026)

Exelixis' (EXEL) quarterly Total Current Liabilities came in at $371.0 million in Q2 2026, down 7.05% year-on-year from $399.1 million in Q2 2025, and down 8.55% quarter-over-quarter from $405.6 million in Q1 2026.

Exelixis (EXEL) Total Current Liabilities (2010 - 2026) Analysis & Trends

Exelixis' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $371.0 million for Q2 2026.

  • On a quarterly basis, Total Current Liabilities fell 7.05% year-over-year to $371.0 million in Q2 2026; TTM through Apr 2026 was $371.0 million, a 7.05% decrease from a year earlier, with the FY2026 full-year figure at $405.6 million, changed 0.46% from the prior year.
  • Total Current Liabilities eased to $371.0 million in Q2 2026 per EXEL's latest filing, from $405.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $405.6 million in Q1 2026 and bottomed at $289.1 million in Q2 2022.
  • The 5-year median for Total Current Liabilities is $371.0 million (2026), against an average of $356.5 million.
  • Across the five-year window, Total Current Liabilities jumped 35.5% in 2022 and fell 7.05% in 2026, its largest moves.
  • Year by year, Total Current Liabilities stood at $324.4 million in 2022, then advanced by 21.56% to $394.3 million in 2023, then climbed by 0.02% to $394.3 million in 2024, then declined by 5.22% to $373.8 million in 2025, then fell by 0.75% to $371.0 million in 2026.
  • Per Business Quant, the three latest EXEL Total Current Liabilities figures stand at $371.0 million (Q2 2026), $405.6 million (Q1 2026), and $373.8 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 370.98 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 370.98 Mn
Jan 2, 2026 405.64 Mn
Oct 3, 2025 373.78 Mn
Jul 4, 2025 336.11 Mn
Apr 4, 2025 399.10 Mn
Jan 3, 2025 403.77 Mn
Sep 27, 2024 394.35 Mn
Jun 28, 2024 345.70 Mn
Mar 29, 2024 373.01 Mn
Dec 29, 2023 394.28 Mn
Sep 29, 2023 376.82 Mn
Jun 30, 2023 339.62 Mn
Mar 31, 2023 327.60 Mn
Dec 30, 2022 324.36 Mn
Sep 30, 2022 301.73 Mn
Jul 1, 2022 304.52 Mn
Apr 1, 2022 289.08 Mn
Dec 31, 2021 337.59 Mn
Oct 1, 2021 269.51 Mn
Jul 2, 2021 255.33 Mn